TransEnterix, Inc. to present at the Ladenburg Thalmann 2015 Healthcare Conference
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE MKT: TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the Ladenburg Thalmann 2015 Healthcare Conference at the Sofitel Hotel in New York. The presentation is scheduled to take place at 2:30 pm Eastern Time on Tuesday, September 29, 2015.
To access the live audio webcast or archived recording, use the following link http://ir.transenterix.com/events.cfm. The replay will be available on the company’s website.
About TransEnterix
TransEnterix is a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery. The company is focused on the development and commercialization of the SurgiBot™ system, a minimally invasive surgical robotic system that allows the surgeon to be patient-side within the sterile field. For more information, visit the company's website at www.transenterix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150915005197/en/
TransEnterix, Inc.
Investor Contact:
Mark Klausner,
443-213-0501
[email protected]
or
Media
Contact:
Mohan Nathan, 919-917-6559
[email protected]
Source: TransEnterix, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Allies of Skin Celebrates the Launch of Peptint with an Exclusive Los Angeles Event Featuring Amber Mark
- The Horseshoe Bay Life Premieres on REAL Shows Network, Showcasing the Luxury Lifestyle, Real Estate, and People of Horseshoe Bay, Lake LBJ, and the Texas Hill Country
- In HelloNation, Insurance Expert James L. Reagle Discusses How to Determine Homeowners Insurance Needs
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share